No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
68 |
4. Check minimum number of eventsNone |
68 |
5. Include endpointsNone |
68 |
6. Filter based on genotype QC (FinnGen only) |
68 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Neurofibromatosis, type 2
based on the number of shared cases.
Similar with more cases:
- Phakomatoses, not elsewhere classified
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 68 | 42 | 26 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 44.77 | 43.31 | 47.14 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003396) Base excess in Arterial blood by calculation
20
45
5.88
9.07
8.4
5.8
mmol/l
0.2
2.1
1.00
15
39
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
33
6.03
7.87
7.6
10.2
mmol/l
24.5
24.3
0.07
16
33
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
10
14
8.20
6.89
12.8
5.5
mmol/l
24.4
25.4
—
10
14
(4035726)
16
38
5.20
6.71
1.3
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
36
166
3.48
6.04
2.4
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
20
62
4.15
6.03
1.5
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
15
41
4.41
5.26
10.8
9.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
13
32
4.79
5.16
9.9
7.0
mmol/l
1.1
1.2
0.18
13
32
(3014007) Fractional oxyhemoglobin in Arterial blood
11
24
5.27
4.98
12.8
5.3
%
96.6
94.8
1.94
11
24
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
28
123
3.17
4.89
2.3
2.4
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
11
25
5.06
4.76
12.4
5.0
%
1.1
1.3
0.51
11
25
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
11
25
5.06
4.76
12.8
5.0
%
0.6
0.7
0.45
11
25
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
6
12.79
4.38
3.1
6.0
nmol/l
2.4
1.0
—
7
6
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
6
10.80
3.57
2.5
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
6
10.80
3.57
3.0
3.3
umol/l
382.5
317.7
—
6
6
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
6
10.80
3.57
2.5
1.2
nmol/l
0.6
0.4
—
6
6
(40768804) Tissue Pathology biopsy report
37
217
2.55
3.50
3.0
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
40
246
2.52
3.39
4.1
4.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
20
5.01
3.24
10.1
7.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
35
3.56
3.08
4.2
3.8
—
—
—
0
0
(3012544) pH of Venous blood
13
47
3.18
3.01
4.0
9.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
9
22
4.55
3.00
1.2
2.3
e6/l
0.7
0.0
—
9
22
(3007853) Bacteria identified in Skin by Aerobe culture
16
68
2.77
2.81
1.3
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
32
193
2.24
2.66
7.7
6.3
g/l
36.8
36.0
0.39
27
186
(3032080) INR in Blood by Coagulation assay
30
180
2.19
2.49
5.8
6.8
inr
1.0
1.1
—
7
47
(3052851) Hemolysis interference index of Serum or Plasma
7
17
4.46
2.43
4.0
2.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
9
5.89
2.25
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
153
0.33
2.12
5.2
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
27
3.22
2.01
4.4
5.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
11
4.81
1.97
1.6
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
81
2.28
1.94
2.3
3.1
e6/l
4.4
3.4
—
10
41
(3004119) Hemoglobin [Mass/volume] in Venous blood
7
22
3.42
1.94
2.6
6.9
g/l
142.6
130.3
—
7
22
(3000494) Fungus identified in Specimen by Culture
14
68
2.33
1.86
2.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
27
171
1.96
1.85
2.1
1.9
pmol/l
103.7
94.9
0.39
16
85
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
48
0.00
1.78
0.0
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
47
368
1.90
1.61
3.4
3.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
122
0.36
1.57
4.6
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
22
2.89
1.47
1.3
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
58
498
2.12
1.37
14.7
9.6
ml/min/173m2
97.4
89.4
1.42
53
402
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
22
144
1.78
1.30
2.8
2.8
u/l
45.8
60.9
2.42
17
133
(3022313) Gas panel - Capillary blood
6
25
2.53
1.27
2.3
6.9
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
19
2.76
1.24
2.0
8.6
g/l
3.4
3.4
—
5
19
(3050129) First trimester maternal screen panel - Serum or Plasma
0
34
0.00
1.19
0.0
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
41
326
1.65
1.16
7.3
12.0
e9/l
4.5
4.0
0.72
36
289
(3042936) Bacteria identified in Isolate by Culture
12
67
1.96
1.13
4.1
2.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
49
410
1.70
1.11
7.8
7.6
u/l
71.3
77.4
0.71
49
379
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
21
2.49
1.11
3.2
4.4
mmol/l
27.0
23.9
—
5
21
(3020891) Body temperature
5
22
2.37
1.05
4.8
4.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
28
0.00
1.00
0.0
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
55
485
1.70
0.90
18.2
16.1
%
13.5
13.5
0.08
55
478
(3036481) Cortisol [Moles/volume] in Serum or Plasma
11
65
1.83
0.88
2.5
1.9
nmol/l
344.7
386.0
0.40
11
58
(3013115) Eosinophils [#/volume] in Blood
35
281
1.51
0.86
5.8
8.9
e9/l
0.3
0.2
0.96
28
253
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
98
0.47
0.86
2.6
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
108
0.51
0.81
3.0
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
25
0.00
0.81
0.0
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
9
53
1.80
0.79
2.2
2.2
u/l
27.0
27.3
—
9
43
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
23
2.26
0.78
1.0
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
145
1.54
0.78
5.6
9.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
61
561
1.85
0.76
19.1
12.4
mg/l
21.7
20.3
0.13
48
416
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
25
192
1.48
0.74
3.2
3.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
34
278
1.45
0.73
5.4
8.2
e9/l
2.1
1.9
0.27
27
250
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
94
0.50
0.73
1.4
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
26
1.99
0.72
2.0
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
27
1.92
0.70
1.8
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
33
271
1.42
0.68
5.5
8.3
e9/l
0.0
0.0
0.81
25
242
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
131
1.51
0.68
4.3
3.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
97
1.56
0.65
2.6
2.9
e6/l
0.5
0.7
—
8
58
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
29
1.78
0.65
1.4
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
23
179
1.43
0.63
6.9
8.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
20
0.00
0.61
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
20
0.00
0.61
0.0
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
63
594
1.82
0.61
17.7
11.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
21
0.00
0.61
0.0
1.2
—
17.7
—
0
5
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
21
0.00
0.61
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
31
258
1.37
0.57
7.7
9.8
e9/l
0.0
0.0
0.00
21
212
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
62
1.52
0.56
4.3
7.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
15
110
1.47
0.55
4.8
4.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
32
271
1.34
0.51
5.7
8.3
e9/l
0.7
0.6
1.22
25
240
(3000492) Spirometry study
7
47
1.54
0.49
2.1
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
93
0.61
0.46
4.8
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
19
152
1.35
0.43
1.7
1.8
mmol/l
1.3
1.4
0.12
19
133
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
21
171
1.33
0.43
3.6
3.1
ng/l
19.8
19.8
0.00
11
101
(3049717) Cytology report of Urine Cyto stain
0
16
0.00
0.41
0.0
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
42
381
1.27
0.36
4.1
4.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
6
43
1.43
0.36
3.2
5.1
e9/l
62.5
71.4
—
6
33
(3026008) Bacteria identified in Urine by Culture
17
138
1.31
0.35
3.8
2.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
129
0.74
0.31
3.0
5.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
62
1.33
0.29
1.8
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
62
1.33
0.29
1.8
2.0
—
—
—
0
0
(3015736) pH of Urine
25
218
1.23
0.29
4.0
3.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
65
1.26
0.28
1.3
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
158
0.78
0.27
2.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
37
1.38
0.24
1.0
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
39
1.30
0.23
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
12
0.00
0.21
0.0
2.8
—
23.2
—
0
7
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
9.2
—
0
13
(3003740) Influenza virus B Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
18
203
0.85
0.18
3.2
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
55
529
1.21
0.18
20.2
14.6
%
40.4
40.4
0.01
46
421
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
84
1.22
0.15
1.7
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
17
153
1.15
0.12
3.1
3.0
—
—
—
0
0
(3019225) pH of Specimen
5
44
1.15
0.10
17.4
4.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
63
1.12
0.08
2.3
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
72
0.82
0.08
1.3
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
20
213
0.91
0.07
3.6
3.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
9
102
0.86
0.07
1.8
1.5
nmol/l
21.1
21.6
—
9
90
(3041096) Erythrocytes [Presence] in Urine by Automated
15
161
0.91
0.06
2.5
2.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
35
340
1.06
0.04
4.2
4.1
—
39.8
—
0
5
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
113
1.08
0.02
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
17
171
0.99
0.00
1.4
1.5
—
—
—
0
0
(3013512) EKG study
14
137
1.03
0.00
3.7
2.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
44
438
1.01
0.00
3.0
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5
56
0.88
0.00
1.2
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
2.6
—
0
6
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
280.2
—
0
6
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4062490)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
25.7
—
0
6
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
50
1.00
0.00
2.2
1.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
6.0
—
0
6
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
-0.00
0.0
1.2
—
266.8
—
0
5
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
-0.00
0.0
38.0
—
154.0
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
1597.4
—
0
5
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
2.2
—
4.4
—
0
5
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
2.4
—
4.0
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
3.6
—
14.7
—
0
5
(3003434) Protein [Mass/volume] in Pleural fluid
0
5
0.00
-0.00
0.0
1.6
—
37.7
—
0
5
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
3.0
—
0.6
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
1.4
—
41.4
—
0
5
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_NEUROFIBROMATOSIS_2 – Neurofibromatosis, type 2
GWS hits: 3
This endpoint is excluded (different definition than used in FinnGen).